Skip to main content
HLB PANAGENE Co., LTD. logo

HLB PANAGENE Co., LTD. — Investor Relations & Filings

Ticker · 046210 ISIN · KR7046210001 KO Professional, scientific and technical activities
Open in API
Filings indexed 266 across all filing types
Latest filing 2025-04-22 Major Shareholding Noti…
Country KR South Korea
Listing KO 046210

About HLB PANAGENE Co., LTD.

https://www.hlbpanagene.com/

HLB PANAGENE is a molecular diagnostics company specializing in proprietary Peptide Nucleic Acid (PNA) technology. The company develops, manufactures, and supplies a range of in vitro diagnostic (IVD) products for personalized medicine, with a focus on oncology and infectious diseases. Its portfolio includes diagnostic solutions for various cancers, such as lung, colorectal, and thyroid, by detecting key genetic mutations. The company also offers real-time PCR-based kits for infectious agents like HPV and STIs. Leveraging its PNA platform for high accuracy and rapid analysis, HLB PANAGENE provides PNA materials and diagnostic kits to a global market. Through its subsidiary, the company is expanding its capabilities into immunodiagnostics and point-of-care testing.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including conversion price adjustments for convertible bonds, and identifies the reporting entity (HLB Co., Ltd.) and its special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-04-22 Korean
전환가액의조정
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing titled '전환가액의조정' (Adjustment of Conversion Price) for HLB Panagene. It details the adjustment of the conversion price for convertible bonds due to a decline in market price, including the calculation methodology and the resulting change in the number of convertible shares. This type of disclosure regarding capital structure and financing instruments falls under 'Capital/Financing Update' (CAP).
2025-04-18 Korean
전환가액의조정
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing from HLB Panagene regarding the 'Adjustment of Conversion Price' for convertible bonds. This type of disclosure relates to changes in the company's capital structure and financial instruments. Under the provided definitions, announcements regarding capital changes, including adjustments to conversion prices of debt instruments, fall under the 'Share Issue/Capital Change' (SHA) category, as it directly impacts the potential equity dilution and capital structure of the firm.
2025-04-18 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회결과' (Regular General Meeting of Shareholders Results) and provides a detailed breakdown of the resolutions passed during the meeting held on 2025-03-24, including financial statement approval, dividend status, and board/auditor appointments. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2025-03-24 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement (under 1,000 characters) regarding the scheduling of an Investor Relations (IR) meeting/presentation. It provides the date, time, location, and purpose of the event. According to the 'Menu vs Meal' rule, since this is an announcement of an upcoming event/presentation rather than the presentation material itself, it falls under the category of a regulatory announcement regarding corporate events.
2025-03-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (HLB Co., Ltd.) and its special related parties in HLB Panagene Inc. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2025-03-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.